215
Participants
Start Date
May 8, 2022
Primary Completion Date
April 30, 2026
Study Completion Date
December 31, 2026
[O-15]-Water PET Myocardial Perfusion Imaging (MPI)
\[15-O\]-H2O injection is a novel PET imaging agent labeled with the radioisotope \[15-O\] administered as an intravenous (IV) injection. Participants will receive \[15-O\]-H2O treatment twice as a part of a single day imaging session. All participants will receive two IV boluses of \[15-O\]-H2O injection in a peripheral vein; one at rest and one during pharmacological stress.
RECRUITING
University of Pittsburgh Medical Center, Pittsburgh
RECRUITING
University of Virginia Medical Center, Charlottesville
WITHDRAWN
BAMF Healthcare, Grand Rapids
RECRUITING
University of Iowa, Iowa City
RECRUITING
Mayo Clinic, Rochester
RECRUITING
Washington University, St Louis
RECRUITING
UT Southwestern Medical Center, Dallas
RECRUITING
University of Ottawa Heart Institute, Ottawa
RECRUITING
Aarhus University Hospital, Aarhus
RECRUITING
University Hospital Freiburg, Clinic for Nuclear Medicine, Freiburg im Breisgau
RECRUITING
Department of Cardiology and Angiology, Hannover Medical School, Hanover
RECRUITING
Sahlgrenska University Hospital, Gothenburg
NOT_YET_RECRUITING
Norrland University Hospital Heart Center, Umeå
Lead Sponsor
MedTrace Pharma A/S
INDUSTRY